Literature DB >> 10186478

The emergence of managed care in Europe. Some thoughts on the politics of healthcare reform.

C Elze1.   

Abstract

It is the purpose of this paper to demonstrate that healthcare reform in Europe can be successful only if it leads to more efficient resource use while maintaining a large degree of equity in the system. Globalisation is undermining the social contracts that established Europe's egalitarian societies after World War II. While socialised healthcare will continue to be an essential building block of social cohesion, public expenditures must be contained. The only approach to maintaining equity of access and financing in the face of a mounting resource constraint is to embark upon a radical re-engineering of the entire healthcare supply chain, introducing and adapting proven US managed-care techniques to the European environment. Through enabling legislation, most European countries are in a phase of testing the feasibility, cost effectiveness and quality enhancement potential of managed-care approaches, before applying them more broadly. While political opposition to change on the part of those whose current positions are threatened continues to run high, the practice of medicine can be expected to converge on the basis of standards of care and information technology over the next 10 to 15 years.

Mesh:

Year:  1998        PMID: 10186478     DOI: 10.2165/00019053-199814001-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  3 in total

1.  Are national drug expenditure control policies compatible with a single European market?

Authors:  J Rovira
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

2.  The UK pharmaceutical market. An overview.

Authors:  A Towse
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

3.  Healthcare reform in Europe.

Authors:  P Belien
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

  3 in total
  1 in total

1.  Healthcare and the tooth fairy. A merger that won't result in 'smarter' medicine.

Authors:  J Avorn
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.